Belantamab Mafodotin in Combination with Vrd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-Vrd Trial

Authors: Gonzalez-Calle, Veronica ^*, Rodriguez Otero, Paula ^*, Rey-Bua, Beatriz ^*, De La Rubia, Javier ^*, De Arriba, Felipe ^*, Cabañas, Valentin ^*, Garcia, Esther González ^*, Ocio, Enrique M., Encinas, Cristina ^*, Suarez Cabrera, Alexia ^*, Bargay, Joan ^*, Martinez Lopez, Joaquin ^*, Gonzalez, Marta Sonia ^*, Hernandez-Rivas, Jose Angel ^*, Rosiñol, Laura ^*, Hernández, Miguel-Teodoro ^*, Paiva, Bruno ^*, Cedena Romero, Maria Teresa ^*, Puig, Noemi, Lahuerta, Juan-José ^*, Bladé, Joan ^*, San-Miguel, Jesús, Mateos, Maria-Victoria

Source: In Blood 15 November 2022 140 Supplement 1:7286-7288

Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents

Authors: De la Iglesia Iñigo, Silvia, López-Jorge, Carmen Elsa, Gómez-Casares, Maria Teresa, Lemes Castellano, Angelina, Martín Cabrera, Pedro, López Brito, Jezabel, Suárez Cabrera, Alexia, Molero Labarta, Teresa

Source: In Leukemia Research 2009 33(6):810-816

GEM2017FIT Trial: Induction Therapy with Bortezomib-Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) Versus Carfilzomib, Lenalidomide and Dexamethasone (KRd) Plus/Minus Daratumumab (D), 18 Cycles, Followed By Consolidation and Maintenance Therapy with Lenalidomide and Daratumumab: Phase III, Multicenter, Randomized Trial for Elderly Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients Aged between 65 and 80 Years

Authors: Mateos, Maria-Victoria, Paiva, Bruno, Cedena Romero, Maria Teresa, Puig, Noemi, Sureda Balari, Anna Maria, Oriol, Albert, Ocio, Enrique M, Rosiñol, Laura, González-Montes, Yolanda, Bargay, Juan Jose, Gonzalez Garcia, Esther, Hernández Garcia, Miguel Teodoro, Ramirez, Angel, Suarez-Cabrera, Alexia, Blanchard, María-Jesús, Garzón, Sebastián, Casado Montero, Luis Felipe, Cabanas Perianes, Valentin, Pérez De Oteyza, Jaime, Gironella, Mercedes, Martinez-Lopez, Joaquin, -Teruel, Ana-Isabel, Delgado, Pilar, Prieto, Elena, Lahuerta Palacios, Juan Jose, Bladé, Joan, San Miguel, Jesus

Source: In Blood 2 November 2023 142 Supplement 1:209-209

Single-Agent Ibrutinib As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice in Spain

Authors: Abrisqueta Costa, Pau ^*, Loscertales, Javier ^*, Terol, Maria Jose ^*, Ramirez Payer, Angel ^*, Ortiz Pareja, Macarena ^*, Perez, Inmaculada ^*, Cuellar, Carolina ^*, Fernandez De La Mata, Margarita ^*, Rodriguez, Alicia ^*, Lario, Ana ^*, Delgado, Julio, Godoy, Ana Cristina ^*, Arguiñano, Jose M ^*, Berruezo, Maria José ^*, Oliveira, Ana C ^*, Hernandez-Rivas, Jose Angel ^*, García-Malo, María-Dolores ^*, Medina, Angeles ^*, García Martín, Paloma ^*, Osorio-Prendes, Santiago ^*, Baltasar, Patricia ^*, Fernandez, Miguel ^*, Marco, Fernando ^*, Vidal, María-Jesús ^*, Smucler Simonovich, Alicia Susana ^*, Lopez Rubio, Montserrat ^*, Jarque, Isidro ^*, Suárez Cabrera, Alexia ^*, Fernandez, Ruben ^*, Lancharro Anchel, Aima ^*, Rios Herranz, Eduardo ^*, Losada, Carmen ^*, Pérez Persona, Ernesto ^*, Garcia, Ricardo Francisco ^*, Ramos, Rafael ^*, Yáñez, Lucrecia ^*, Bello, Jose Luis ^*, Loriente, Cristina ^*, Villanueva, Miguel ^*

Source: In Blood 5 November 2020 136 Supplement 1:32-33

Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Authors: Garcia-Marco, Jose, Baltasar Tello, Patricia ^*, Garcia, Esther González ^*, Ríos Herranz, Eduardo ^*, Ramirez Payer, Angel ^*, Terol Castera, María José ^*, Champ, Diana ^*, Medina Perez, Angeles ^*, Gironella, Mercedes ^*, Rodríguez Fernández, Alicia ^*, Muntañola Prat, Ana ^*, Suárez Cabrera, Alexia ^*, Jurado Chacón, Manuel ^*, Fernández Zarzoso, Miguel ^*, Rodríguez, Mercedes ^*, Clavel, Juana ^*, Dourdil Sahun, Maria Victoria ^*, Ferra Coll, Christelle M ^*, Pérez Persona, Ernesto ^*, Marrero Santos, Carmen Milagros ^*, Forés, Rafael ^*, Delgado, Julio

Source: In Blood 8 December 2017 130 Supplement 1:4321-4321

Assessment of Clinical Differences Between Starting Antimyeloma Treatment at Biological Relapse or at Clinical Relapse: Preliminary Results of an Observational Prospective Registry

Authors: Gironella, Mercedes ^*, Bergua, Juan ^*, Fernández de Larrea, Carlos ^*, Escalante, Fernando ^*, González, Maria ^*, Martínez Chamorro, Carmen ^*, López, Aurelio ^*, Pérez-Persona, E ^*, Lahuerta, Juan José ^*, Somilinos, Nieves ^*, Soler, Alfonso ^*, Gonzalez, Yolanda ^*, Suárez Cabrera, Alexia ^*, Barez, Abelardo ^*, Cabañas, Valentin ^*, Sampol, Antonia ^*, Gonzalez, Ana Pilar ^*, Lostaunau, Giselle ^*, Vilanova, David ^*, Alegre, Adrian

Source: In Blood 3 December 2015 126(23):4231-4231